company background image
AHC

Austco HealthcareASX:AHC Stock Report

Market Cap

AU$42.6m

7D

-3.3%

1Y

49.5%

Updated

26 Oct, 2021

Data

Company Financials
AHC fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

AHC Overview

Austco Healthcare Limited, together with its subsidiaries, manufactures, distributes, supplies, and services healthcare and communication equipment and software in Australia, New Zealand, Asia, Europe, and North America.

Price History & Performance

Summary of all time highs, changes and price drops for Austco Healthcare
Historical stock prices
Current Share PriceAU$0.14
52 Week HighAU$0.085
52 Week LowAU$0.17
Beta0.71
1 Month Change0%
3 Month Change0%
1 Year Change49.49%
3 Year Change55.91%
5 Year Change62.92%
Change since IPO-51.67%

Recent News & Updates

Jul 07
Returns On Capital Are Showing Encouraging Signs At Austco Healthcare (ASX:AHC)

Returns On Capital Are Showing Encouraging Signs At Austco Healthcare (ASX:AHC)

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

Apr 29
Here's Why I Think Austco Healthcare (ASX:AHC) Might Deserve Your Attention Today

Here's Why I Think Austco Healthcare (ASX:AHC) Might Deserve Your Attention Today

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...

Mar 16
Can Austco Healthcare (ASX:AHC) Continue To Grow Its Returns On Capital?

Can Austco Healthcare (ASX:AHC) Continue To Grow Its Returns On Capital?

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Shareholder Returns

AHCAU Medical EquipmentAU Market
7D-3.3%0.3%0.8%
1Y49.5%-7.4%24.4%

Return vs Industry: AHC exceeded the Australian Medical Equipment industry which returned -7.4% over the past year.

Return vs Market: AHC exceeded the Australian Market which returned 24.4% over the past year.

Price Volatility

Is AHC's price volatile compared to industry and market?
AHC volatility
AHC Beta0.71
Industry Beta0.57
Market Beta1

Stable Share Price: AHC is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: AHC's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1986n/aClayton Astleshttps://www.austcohealthcare.com

Austco Healthcare Limited, together with its subsidiaries, manufactures, distributes, supplies, and services healthcare and communication equipment and software in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP based nurse call solution for healthcare, aged care, and acute care facilities. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020.

Austco Healthcare Fundamentals Summary

How do Austco Healthcare's earnings and revenue compare to its market cap?
AHC fundamental statistics
Market CapAU$42.63m
Earnings (TTM)AU$3.42m
Revenue (TTM)AU$31.25m

12.0x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AHC income statement (TTM)
RevenueAU$31.25m
Cost of RevenueAU$14.54m
Gross ProfitAU$16.71m
ExpensesAU$13.29m
EarningsAU$3.42m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.012
Gross Margin53.48%
Net Profit Margin10.96%
Debt/Equity Ratio0%

How did AHC perform over the long term?

See historical performance and comparison

Valuation

Is Austco Healthcare undervalued compared to its fair value and its price relative to the market?

32.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: AHC (A$0.15) is trading below our estimate of fair value (A$0.22)

Significantly Below Fair Value: AHC is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: AHC is good value based on its PE Ratio (12x) compared to the Australian Medical Equipment industry average (13.6x).

PE vs Market: AHC is good value based on its PE Ratio (12x) compared to the Australian market (20x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AHC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AHC is good value based on its PB Ratio (2.1x) compared to the AU Medical Equipment industry average (4.5x).


Future Growth

How is Austco Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Austco Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Austco Healthcare performed over the past 5 years?

74.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AHC has a large one-off gain of A$2.0M impacting its June 30 2021 financial results.

Growing Profit Margin: AHC's current net profit margins (11%) are higher than last year (7.9%).


Past Earnings Growth Analysis

Earnings Trend: AHC has become profitable over the past 5 years, growing earnings by 74% per year.

Accelerating Growth: AHC's earnings growth over the past year (36.7%) is below its 5-year average (74% per year).

Earnings vs Industry: AHC earnings growth over the past year (36.7%) underperformed the Medical Equipment industry 74.9%.


Return on Equity

High ROE: AHC's Return on Equity (17.7%) is considered low.


Financial Health

How is Austco Healthcare's financial position?


Financial Position Analysis

Short Term Liabilities: AHC's short term assets (A$21.7M) exceed its short term liabilities (A$7.2M).

Long Term Liabilities: AHC's short term assets (A$21.7M) exceed its long term liabilities (A$643.0K).


Debt to Equity History and Analysis

Debt Level: AHC is debt free.

Reducing Debt: AHC has no debt compared to 5 years ago when its debt to equity ratio was 16.4%.

Debt Coverage: AHC has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: AHC has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Austco Healthcare current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AHC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AHC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AHC's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.0yrs

Average board tenure


CEO

Clayton Astles

6.25yrs

Tenure

AU$791,257

Compensation

Mr. Clayton Astles has been the Chief Executive Officer of Austco Healthcare Limited (formerly known as Azure Healthcare Limited) since July 31, 2015 and serves as its Managing Director. Mr. Astles serves...


CEO Compensation Analysis

Compensation vs Market: Clayton's total compensation ($USD593.15K) is above average for companies of similar size in the Australian market ($USD301.38K).

Compensation vs Earnings: Clayton's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: AHC's board of directors are considered experienced (6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: AHC insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Austco Healthcare Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Austco Healthcare Limited
  • Ticker: AHC
  • Exchange: ASX
  • Founded: 1986
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: AU$42.628m
  • Shares outstanding: 284.19m
  • Website: https://www.austcohealthcare.com

Number of Employees


Location

  • Austco Healthcare Limited
  • 1/31 Sabre Drive
  • Port Melbourne
  • Victoria
  • 3207
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 07:01
End of Day Share Price2021/10/26 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.